CardiAMP bone marrow cell therapy for heart failure
Part of Heart & circulation clinical trials.
This trial tests a new treatment using your own bone marrow cells to help your heart pump better. It's for people with heart failure after a heart attack whose heart function is moderately reduced.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure symptoms that make you a bit short of breath with everyday activities (NYHA Class II or III).
- Your heart failure is caused by a past heart attack (not other reasons).
- Your heart's pumping ability, called ejection fraction, is between 20% and 40%.
- You have been on stable heart failure medications and devices (like a pacemaker or defibrillator) for at least 3 months.
- A blood test for NT-proBNP shows a level greater than 500 pg/mL.
- A test of your own bone marrow cells shows they are a good match for the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether injecting special heart cells (called HiCM-188) into the heart during bypass surgery can help improve heart function in people with advanced heart failure. The goal is to see if the cells can strengthen the heart muscle and help you feel better.
This trial tests whether injecting lab-grown heart cells into the heart can help people with heart failure whose heart pumps less than 40% of normal. It may help improve heart function and reduce symptoms.
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
This trial tests whether injecting special heart muscle cells (made from stem cells) during a heart bypass or a heart pump surgery can help improve your heart's function. It is for people with severe heart failure who are already planning one of these surgeries.
This study tests a new treatment using donor stem cells injected into the heart during scheduled bypass surgery. The goal is to see if these cells help improve heart function in people with heart failure due to blocked arteries and a weak heart pump.
This Phase 1 study tests a treatment made from stem cells to grow heart muscle cells (“cardiomyocytes”) for people with long-lasting (chronic) heart weakness after a prior heart attack. It aims to see if the therapy can improve heart function and is safe in carefully selected patients.
Hear when a new Ischemic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.